Translational Research on Esophageal Cancer: From Cell Line to Clinic
(Translationeel onderzoek naar slokdarmkanker: Van cellijn tot kliniek)
2011-11-02
Doctoral Thesis
| Related Files |
|---|
View PDF Version
(111102_Boonstra, Jurjen Johannes.pdf, 4.9MB) |
Worldwide esophageal cancer is a signifi cant and an increasing health problem. In 2005, there were 497,700 new cases, and the prevalence is expected to increase by approximately 140% by 2025. Esophageal squamous cell carcinoma (ESCC) accounts for most of the cases of esophageal cancer worldwide (2); however, in a number of Western countries, including the Netherlands, there has been a modest decline in the incidence of ESCC and a steep rise in the frequency of esophageal adenocarcinoma (EAC).
The studies performed in this thesis were fi nancially supported by: The SK foundation, Stichting Erasmus Heelkundig Kankeronderzoek (SEHK) Revolving fund FC0991 Erasmus MC Rotterdam Financial support for the printing of this thesis was kindly provided by: Erasmus Universiteit Rotterdam Erasmus MC afdeling Heelkunde De Nederlandse Vereniging voor Gastroenterologie J. E. Jurriaanse Stichting
- patient
- cancer
- esophageal
- tumor
- cell lines
- adenocarcinoma
- eac cell lines
- jurjen
- bw.indd
- boomstra
- 03-10-11
- chemotherapy
- study
- survival
- surgery
- carcinoma
- esophagus
- barrett
- esophageal adenocarcinoma
- resection
